Zevra Therapeutics Accounts Receivable (Quarterly) Analysis

Zevra Therapeutics Inc (ZVRA)

4.73 -0.03 (-0.63%) USD | NASDAQ | May 17, 16:00

4.73 0.00 (0.00%) After-Hours: 20:00

Accounts Receivable (Quarterly) Chart

Historical Accounts Receivable (Quarterly) Data

View and export this data back to 2015. Upgrade now.

Date	Value
March 31, 2024	8.305M
December 31, 2023	16.12M
September 30, 2023	9.927M
June 30, 2023	11.60M
March 31, 2023	7.822M
December 31, 2022	7.185M
September 30, 2022	6.583M
June 30, 2022	2.82M
March 31, 2022	3.32M
December 31, 2021	1.421M
September 30, 2021	1.619M
June 30, 2021	1.888M
March 31, 2021	11.31M
December 31, 2020	2.442M
September 30, 2020	2.202M
June 30, 2020	2.093M
March 31, 2020	2.265M

Date	Value
December 31, 2019	1.681M
September 30, 2019	1.638M
June 30, 2019
March 31, 2019
December 31, 2018	0.00
September 30, 2018	0.00
June 30, 2018
March 31, 2018	1.511M
December 31, 2017	2.005M
September 30, 2017	2.503M
June 30, 2017	0.00
March 31, 2017	0.00
December 31, 2016	5.003M
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015	0.00

Accounts Receivable Definition

Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.

Read full definition.

Accounts Receivable (Quarterly) Range, Past 5 Years

1.421M

Minimum

Dec 2021

16.12M

Maximum

Dec 2023

5.381M

Average

2.82M

Median

Jun 2022

Accounts Receivable (Quarterly) Benchmarks